These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7599759)

  • 1. ACE inhibition preserves renal function better than beta-blockade in the treatment of essential hypertension.
    Himmelmann A; Hansson L; Hansson BG; Hedstrand H; Skogström K; Ohrvik J; Furängen A
    Blood Press; 1995 Mar; 4(2):85-90. PubMed ID: 7599759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of angiotensin-converting enzyme inhibition versus conventional antihypertensive therapy on the glomerular filtration rate.
    Hansson L
    Cardiology; 1995; 86 Suppl 1():30-3. PubMed ID: 7614504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term renal preservation in essential hypertension. Angiotensin converting enzyme inhibition is superior to beta-blockade.
    Himmelmann A; Hansson L; Hansson BG; Hedstrand H; Skogström K; Ohrvik J; Furängen A
    Am J Hypertens; 1996 Sep; 9(9):850-3. PubMed ID: 8879340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of cilazapril and amlodipine on kidney function in hypertensive NIDDM patients.
    Velussi M; Brocco E; Frigato F; Zolli M; Muollo B; Maioli M; Carraro A; Tonolo G; Fresu P; Cernigoi AM; Fioretto P; Nosadini R
    Diabetes; 1996 Feb; 45(2):216-22. PubMed ID: 8549868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term effect of lisinopril and atenolol on kidney function in hypertensive NIDDM subjects with diabetic nephropathy.
    Nielsen FS; Rossing P; Gall MA; Skøtt P; Smidt UM; Parving HH
    Diabetes; 1997 Jul; 46(7):1182-8. PubMed ID: 9200654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of lisinopril and atenolol on kidney function in hypertensive NIDDM subjects with diabetic nephropathy.
    Nielsen FS; Rossing P; Gall MA; Skøtt P; Smidt UM; Parving HH
    Diabetes; 1994 Sep; 43(9):1108-13. PubMed ID: 8070610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of angiotensin-converting enzyme inhibition versus beta-adrenergic blockade on aortic stiffness in essential hypertension.
    Savolainen A; Keto P; Poutanen VP; Hekali P; Standertskjöld-Nordenstam CG; Rames A; Kupari M
    J Cardiovasc Pharmacol; 1996 Jan; 27(1):99-104. PubMed ID: 8656666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia).
    Lancet; 1997 Jun; 349(9069):1857-63. PubMed ID: 9217756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of antihypertensive treatment on vascular remodeling in essential hypertensive patients.
    Schiffrin EL; Deng LY; Larochelle P
    J Cardiovasc Pharmacol; 1994; 24 Suppl 3():S51-6. PubMed ID: 7700067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension.
    Petersen LJ; Petersen JR; Talleruphuus U; Møller ML; Ladefoged SD; Mehlsen J; Jensen HA
    Clin Nephrol; 2001 May; 55(5):375-83. PubMed ID: 11393383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correction of remodeling and function of small arteries in human hypertension by cilazapril, an angiotensin I-converting enzyme inhibitor.
    Schiffrin EL
    J Cardiovasc Pharmacol; 1996; 27 Suppl 2():S13-8. PubMed ID: 8723394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of a beta-blocker or a converting enzyme inhibitor on resistance arteries in essential hypertension.
    Schiffrin EL; Deng LY; Larochelle P
    Hypertension; 1994 Jan; 23(1):83-91. PubMed ID: 8282334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of ACE inhibitors and vasodilators on renal function curve in patients with primary hypertension.
    Fliser D; Nowack R; Wolf G; Ritz E
    Blood Press; 1993 Dec; 2(4):296-300. PubMed ID: 8173699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of effects of angiotensin I-converting enzyme inhibition and beta-blockade for 2 years on function of small arteries from hypertensive patients.
    Schiffrin EL; Deng LY
    Hypertension; 1995 Apr; 25(4 Pt 2):699-703. PubMed ID: 7721419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of life with three antihypertensive treatments. Cilazapril, atenolol, nifedipine.
    Fletcher AE; Bulpitt CJ; Chase DM; Collins WC; Furberg CD; Goggin TK; Hewett AJ; Neiss AM
    Hypertension; 1992 Jun; 19(6 Pt 1):499-507. PubMed ID: 1534312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are angiotensin converting enzyme inhibitors superior to beta blockers in retarding progressive renal function decline?
    van Essen GG; Apperloo AJ; Rensma PL; Stegeman CA; Sluiter WJ; de Zeeuw D; de Jong PE
    Kidney Int Suppl; 1997 Dec; 63():S58-62. PubMed ID: 9407423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACE inhibitor versus beta-blocker for the treatment of hypertension in renal allograft recipients.
    Hausberg M; Barenbrock M; Hohage H; Müller S; Heidenreich S; Rahn KH
    Hypertension; 1999 Mar; 33(3):862-8. PubMed ID: 10082500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of cilazapril on renal haemodynamics and function in hypertensive patients: a randomised controlled study versus hydrochlorothiazide.
    Scaglione R; Ganguzza A; Corrao S; Costa R; Paternà S; Cannavo MG; Parrinello G; Di Chiara T; D'Aubert MD; Cottone C
    Blood Press; 1995 Nov; 4(6):363-8. PubMed ID: 8746604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin-converting enzyme inhibition causes deterioration in renal function in one-kidney Goldblatt hypertensive rats with and without renal arterial stenosis.
    Huang WC; Wu JN; Jin JS
    Clin Exp Pharmacol Physiol; 1992 Oct; 19(10):695-703. PubMed ID: 1424298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double blind comparison of perindopril and atenolol in essential hypertension.
    Thurston H; Mimran A; Zanchetti A; Creytens G; Rorive G; Brown CL; Santoni JP
    J Hum Hypertens; 1990 Oct; 4(5):547-52. PubMed ID: 2283644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.